Search research articles
Contact Us
Filters
Showing results (161-170 of 247) with videos related to
Page
of 25
Sort By:
Journal of Diabetes and Its Complications
|
December 8, 2020
Vasopressin associated with renal vascular resistance in adults with longstanding type 1 diabetes with and without diabetic kidney disease
Federica Piani, Trenton Reinicke, Yuliya Lytvyn, et al.
Canadian Journal of Diabetes
|
October 22, 2019
Analysis of Prevalence, Magnitude and Timing of the Dawn Phenomenon in Adults and Adolescents With Type 1 Diabetes: Descriptive Analysis of 2 Insulin Pump Trials
Ilia Ostrovski, Leif E Lovblom, Daniel Scarr, et al.
Kidney International
|
November 1, 2014
Sodium glucose cotransport-2 inhibition and intrarenal RAS activity in people with type 1 diabetes
David Z I Cherney, Bruce A Perkins, Nima Soleymanlou, et al.
Diabetes Care
|
June 13, 2013
Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort
Rodica Pop-Busui, Jiang Lu, Maria Mori Brooks, et al.
Journal of Diabetes and Its Complications
|
March 29, 2017
Agreement between automated and manual quantification of corneal nerve fiber length: Implications for diabetic neuropathy research
Daniel Scarr, Leif E Lovblom, Ilia Ostrovski, et al.
Kidney International
|
March 24, 2020
Renal hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in hyperfiltering people with type 1 diabetes and people with type 2 diabetes and normal kidney function
Erik J M van Bommel, Yuliya Lytvyn, Bruce A Perkins, et al.
Diabetologia
|
April 13, 2019
Molecular regulation of the renin-angiotensin system by sodium-glucose cotransporter 2 inhibition in type 1 diabetes mellitus
Chantal Kopecky, Yuliya Lytvyn, Oliver Domenig, et al.
Diabetes Care
|
March 6, 2014
Sodium-glucose cotransporter 2 inhibition and glycemic control in type 1 diabetes: results of an 8-week open-label proof-of-concept trial
Bruce A Perkins, David Z I Cherney, Helen Partridge, et al.
American Journal of Physiology. Renal Physiology
|
April 7, 2017
Urinary adenosine excretion in type 1 diabetes
Harindra Rajasekeran, Yuliya Lytvyn, Andrea Bozovic, et al.
Diabetes Care
|
June 10, 2019
Exploring Patient Preferences for Adjunct-to-Insulin Therapy in Type 1 Diabetes
Bruce A Perkins, Julio Rosenstock, Jay S Skyler, et al.
Page
of 25
Search research articles
Search
Showing results (161-170 of 247) with videos related to
Sort By:
Page
of 25
Journal of Diabetes and Its Complications
|
December 8, 2020
Vasopressin associated with renal vascular resistance in adults with longstanding type 1 diabetes with and without diabetic kidney disease
Federica Piani, Trenton Reinicke, Yuliya Lytvyn, et al.
Canadian Journal of Diabetes
|
October 22, 2019
Analysis of Prevalence, Magnitude and Timing of the Dawn Phenomenon in Adults and Adolescents With Type 1 Diabetes: Descriptive Analysis of 2 Insulin Pump Trials
Ilia Ostrovski, Leif E Lovblom, Daniel Scarr, et al.
Kidney International
|
November 1, 2014
Sodium glucose cotransport-2 inhibition and intrarenal RAS activity in people with type 1 diabetes
David Z I Cherney, Bruce A Perkins, Nima Soleymanlou, et al.
Diabetes Care
|
June 13, 2013
Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort
Rodica Pop-Busui, Jiang Lu, Maria Mori Brooks, et al.
Journal of Diabetes and Its Complications
|
March 29, 2017
Agreement between automated and manual quantification of corneal nerve fiber length: Implications for diabetic neuropathy research
Daniel Scarr, Leif E Lovblom, Ilia Ostrovski, et al.
Kidney International
|
March 24, 2020
Renal hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in hyperfiltering people with type 1 diabetes and people with type 2 diabetes and normal kidney function
Erik J M van Bommel, Yuliya Lytvyn, Bruce A Perkins, et al.
Diabetologia
|
April 13, 2019
Molecular regulation of the renin-angiotensin system by sodium-glucose cotransporter 2 inhibition in type 1 diabetes mellitus
Chantal Kopecky, Yuliya Lytvyn, Oliver Domenig, et al.
Diabetes Care
|
March 6, 2014
Sodium-glucose cotransporter 2 inhibition and glycemic control in type 1 diabetes: results of an 8-week open-label proof-of-concept trial
Bruce A Perkins, David Z I Cherney, Helen Partridge, et al.
American Journal of Physiology. Renal Physiology
|
April 7, 2017
Urinary adenosine excretion in type 1 diabetes
Harindra Rajasekeran, Yuliya Lytvyn, Andrea Bozovic, et al.
Diabetes Care
|
June 10, 2019
Exploring Patient Preferences for Adjunct-to-Insulin Therapy in Type 1 Diabetes
Bruce A Perkins, Julio Rosenstock, Jay S Skyler, et al.
Page
of 25